| Elixinol Wellness Limited (EXL) ORDINARY FULLY PAID |
Consumer Staple |
$5 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jan 2026 10:02AM |
$0.011 |
$0.011 |
fallen by
0%
|
|
EXL - Price-sensitive ASX Announcement
Full Release
Key Points
- First underlying operating cash flow positive quarter achieved
- Q4 FY25 revenue of $4.1 million, up 9.5% quarter-on-quarter
- 42% revenue increase in Healthy Chef e-commerce sales year-on-year
- Operating costs reduced by 30% in Q4 FY25
- Reestablished position as dominant hemp supplier in Australia
- Company positioned for scalability and profitability with a focus on higher-margin sales
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Zimi Limited (ZMM) ORDINARY FULLY PAID |
Information Technology |
$5 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jan 2026 10:02AM |
$0.007 |
$0.007 |
fallen by
0%
|
|
ZMM - Price-sensitive ASX Announcement
Full Release
Key Points
- Invoiced revenue of $590,000 for the December 2025 quarter.
- Year-on-year revenue growth of 300% compared to December 2024.
- Customer receipts increased to $822,000.
- Progression of 'Senoa Matter' product range to industrialization.
- Advancements in digital sales and development of 'Ask Zimi' AI agent.
- CEO's strategic visit to China to strengthen partnerships.
- Appointment of Todd Milliner to enhance manufacturing expertise.
- Net cash from operating activities was $374,000.
- Total available funding was $958,000.
- Payments to related parties totaled $599,000.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Syntara Limited (SNT) ORDINARY FULLY PAID |
Health Care |
$52 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jan 2026 10:02AM |
$0.035 |
$0.032 |
fallen by
8.57%
|
|
SNT - Price-sensitive ASX Announcement
Full Release
Key Points
- Amsulostat clinical and preclinical data were presented at the ASH Annual Meeting.
- Initiation of the second myelodysplastic syndrome (MDS) study in Australia.
- Received positive European Medicines Agency opinion for Orphan Drug Designation.
- Announcement of a pancreatic cancer Phase 1/2 clinical trial funded by MRFF.
- SNT-4728 Phase 2 iRBD trial fully recruited with data expected in Q2 2026.
- Progression of SNT-9465 into hypertrophic scar study after Phase 1a study.
- Syntara's proforma cash balance at 31 December was $12.3 million.
- Net cash used in operating activities was $3.8 million for the quarter.
- No net cash used/generated from investing and financing activities.
- Cash and cash equivalents at the end of the period totaled $10.5 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| FBR Ltd (FBR) ORDINARY FULLY PAID |
Industrials |
$27 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jan 2026 10:01AM |
$0.003 |
$0.004 |
risen by
33.33%
|
|
FBR - Price-sensitive ASX Announcement
Full Release
Key Points
- Factory Acceptance Test for Hadrian unit completed with a speed record.
- Memorandum of Understanding for Hadrian unit sale to Fraser Lyne Constructions.
- Successful demonstration of shipbuilding robot prototype for Samsung.
- First binding purchase order for Mantis welding robot received.
- Net cash used in operating activities: $2.1 million.
- Cash balance at quarter-end: $870,000.
- Share Subscription Facility of $20 million established.
- Exploration of additional financing options and government grant application.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| 6K Additive, Inc (6KA) CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB |
Materials |
$177 |
Investor Webinar Update
|
29 Jan 2026 10:01AM |
$1.080 |
$1.020 |
fallen by
5.56%
|
|
| Aerometrex Limited (AMX) ORDINARY FULLY PAID |
Industrials |
$26 |
AMX delivers record first half revenue and EBITDA
|
29 Jan 2026 10:01AM |
$0.240 |
$0.275 |
risen by
14.58%
|
|
AMX - Price-sensitive ASX Announcement
Full Release
Key Points
- Aerometrex Limited delivered record first half revenue and EBITDA for the first half of the 2026 financial year.
- The company reported group statutory revenue between $12.75 million and $13.25 million, up 10% to 15% compared to the previous year.
- EBITDA increased significantly, expected between $3.25 million to $3.75 million, marking a 209% to 257% increase from the previous year.
- MetroMap, a key product, achieved a record Annual Contract Value (ACV) of approximately $12.29 million.
- LiDAR services showed a strong recovery with revenue between $6.2 million to $6.6 million.
- The company's cash balance stood at $3.67 million as of 31 December 2025, maintaining stable cash flow for three consecutive quarters.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Starpharma Holdings Limited (SPL) ORDINARY FULLY PAID |
Health Care |
$160 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jan 2026 10:01AM |
$0.350 |
$0.380 |
risen by
8.57%
|
|
SPL - Price-sensitive ASX Announcement
Full Release
Key Points
- Focus on executing strategic partnerships.
- Progress on internal radiopharmaceutical program.
- Highest online sales month for Viraleze™ achieved.
- Cash balance of $18.2 million.
- Payment of USD $5.5 million received from Genentech.
- Advancements in DEP® platform attracting industry attention.
- Participation in JP Morgan and Biotech Showcase conferences.
- Strategic priorities for 2026 include advancing radiotheranostic program.
- Certification as a Great Place to Work.
- Expansion of commercialization opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| L1 Group Limited (L1G) ORDINARY FULLY PAID |
Financials |
$3,157 |
Timing of release of Half Year Financial Results
|
29 Jan 2026 10:00AM |
$1.165 |
$1.230 |
risen by
5.58%
|
|
| Brightstar Resources Limited (BTR) ORDINARY FULLY PAID |
Materials |
$448 |
Trading Halt
|
29 Jan 2026 10:00AM |
$0.630 |
$0.630 |
fallen by
0%
|
|
BTR - Price-sensitive ASX Announcement
Full Release
Key Points
- Trading halt for Brightstar Resources Limited requested on 29 January 2026.
- Halt due to pending announcement of potential capital raising.
- Trading to resume by 2 February 2026 or upon announcement release.
- Halt aims to manage disclosure obligations and market order.
- No reasons identified for denying the trading halt request.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Benz Mining Corp (BNZ) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$522 |
Proposed issue of securities - BNZ
|
29 Jan 2026 10:00AM |
$2.740 |
$2.500 |
fallen by
8.76%
|
|
| Invion Limited (IVX) ORDINARY FULLY PAID |
Health Care |
$8 |
Trading Halt
|
29 Jan 2026 10:00AM |
$0.092 |
$0.092 |
fallen by
0%
|
|
IVX - Price-sensitive ASX Announcement
Full Release
Key Points
- Invion Limited (ASX: IVX) requests a trading halt.
- Trading halt is due to pending capital raising announcement.
- Halt remains until 2 February 2026 or until announcement is made.
- Trading halt assists in managing continuous disclosure obligations.
- Company unaware of reasons against granting the halt.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Benz Mining Corp (BNZ) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$522 |
Transformational A$75 Million Bought Deal
|
29 Jan 2026 9:59AM |
$2.740 |
$2.500 |
fallen by
8.76%
|
|
BNZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Benz Mining Corp secures A$75 million via bought deal.
- Placement driven by demand from leading offshore institutional investors.
- Funds to increase activities at Glenburgh and Mt Egerton Gold Projects.
- Aimed at resource growth, infill drilling, and extension of known mineralisation.
- Pro-forma cash position of ~A$94 million post-placement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aeris Resources Limited (AIS) ORDINARY FULLY PAID |
Materials |
$736 |
QUARTERLY ACTIVITIES REPORT - DEC 2025
|
29 Jan 2026 9:59AM |
$0.675 |
$0.615 |
fallen by
8.89%
|
|
AIS - Price-sensitive ASX Announcement
Full Release
Key Points
- Group copper equivalent production of 10.1kt at AISC of A$4.21/lb.
- Gold production at Cracow was ahead of plan.
- Cash and receivables significantly improved to $106.4 million.
- Completed $80 million placement and $21.6 million share purchase plan.
- Fully repaid $50 million loan facility.
- Encouraging exploration results from Avoca Tank and Budgerygar.
- Drilling commenced at Golden Plateau.
- Safety performance with LTIFR at 1.2.
- One environmental incident occurred at Tritton.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Blaze Minerals Limited (BLZ) ORDINARY FULLY PAID |
Energy |
$4 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Jan 2026 9:59AM |
$0.001 |
$0.002 |
risen by
50%
|
|
BLZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Strategic review of the Ntungamo Project initiated.
- Withdrawal from Loulombo Base Metals Project.
- New project generation initiatives underway.
- Cash and cash equivalents at quarter end: $786,000.
- Payments to related parties totaled $122,000.
- No significant mining production or development during the quarter.
- Estimation of 1.75 quarters of funding available based on current cash flows.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Knosys Limited (KNO) ORDINARY FULLY PAID |
Information Technology |
$5 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jan 2026 9:58AM |
$0.025 |
$0.025 |
fallen by
0%
|
|
KNO - Price-sensitive ASX Announcement
Full Release
Key Points
- Knosys reported cash receipts of $1.7 million for Q2 FY26, a 6.6% increase compared to the previous corresponding period.
- Net operating cash outflow was $1.45 million in Q2 FY26 due to seasonally lower cash receipts.
- Non-recurring restructuring and redundancy expenses were incurred in December 2025 to achieve cost savings.
- The cash balance at the end of December 2025 was $1.9 million, which increased to $3.1 million by the end of January 2026.
- The company signed an agency agreement with Oak Engage to introduce new intranet technology to its Greenorbit customers.
- Knosys is focusing its development efforts on the next-generation Libero X library management solution, expected to launch in FY27.
- There was a structurally lower fixed cost base due to operational restructuring.
- Annual Recurring Revenue (ARR) stood at $9.5 million as of January 2026.
- The company expects to continue its operations and meet business objectives despite low cash flows in the December 2025 quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Great Southern Mining Limited (GSN) ORDINARY FULLY PAID |
Materials |
$42 |
Edinburgh Park Exploration Update
|
29 Jan 2026 9:58AM |
$0.049 |
$0.042 |
fallen by
14.29%
|
|
GSN - Price-sensitive ASX Announcement
Full Release
Key Points
- Extensive quartz-pyrite veining found at Leichhardt Creek.
- No significant economic metal accumulations recorded in assays.
- Molongle identified as a high priority target with pending assays.
- Intermediate epithermal system identified at Molongle.
- Megan Veins target shows potential for gold-silver mineralization.
- Further drilling planned for targets identified in geophysical surveys.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Brazilian Rare Earths Limited (BRE) ORDINARY FULLY PAID |
Materials |
$1,044 |
December 2025 Quarterly Report and Appendix 5B
|
29 Jan 2026 9:58AM |
$4.250 |
$3.800 |
fallen by
10.59%
|
|
BRE - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash outflows from operating activities were $10.8 million.
- Significant cash inflows from financing activities totaled $120 million.
- Transaction costs for equity issues were $3.7 million.
- Ending cash balance for the quarter was $162.4 million.
- No new exploration tenements were acquired; 74 tenements were relinquished.
- Focus on Amargosa Bauxite Project with a low-cost operational plan.
- Amargosa Project scoping study shows robust economic potential.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Stakk Limited (SKK) ORDINARY FULLY PAID |
Information Technology |
$84 |
Stakk targets 15M ARR with new Robinhood deployment
|
29 Jan 2026 9:57AM |
$0.029 |
$0.027 |
fallen by
6.90%
|
|
SKK - Price-sensitive ASX Announcement
Full Release
Key Points
- Stakk aims to achieve a $15.0m Annual Recurring Revenue (ARR) run-rate by 30 June 2026.
- Stakk currently has an ARR of $8.53m, with plans to expand through signed contracts, a strong enterprise pipeline, and product upsell.
- Robinhood is a key client deploying Stakk's Mobile IQ SDK for document-capture liveness detection.
- The Mobile IQ SDK is a security product designed to ensure the authenticity and integrity of document capture.
- Stakk's strategy focuses on expanding ARR by 20% from signed contracts not yet live, 50% from new enterprise pipelines, and 30% from upsells.
- Stakk's platform offers real-time validation of document capture, enhancing security against fraud.
- The deployment with Robinhood validates Stakk's platform maturity and supports its ARR growth objectives.
- Stakk's approach involves monetizing the Mobile IQ SDK as a recurring platform module.
- The company positions itself for growth through organic scaling and targeted acquisitions, with a focus on key global markets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Rimfire Pacific Mining Limited (RIM) ORDINARY FULLY PAID |
Materials |
$44 |
December 2025 Quarterly Activities and Cashflow Report
|
29 Jan 2026 9:57AM |
$0.016 |
$0.016 |
fallen by
0%
|
|
RIM - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant scandium drilling programs completed at Murga and Rabbit Trap.
- Initial assays indicate broad scandium intercepts.
- Aiming for a maiden Mineral Resource estimate for Murga by March 2026.
- Identified a new gold-antimony prospect at Broken Hill.
- Cash balance of $1.5 million as of 31 December 2025.
- Metallurgical study preparations approved for Murga.
- Exploration activities managed under an Earn-In Agreement with Golden Plains Resources.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MRG Metals Limited (MRQ) ORDINARY FULLY PAID |
Materials |
$15 |
JV Partner Sets Start Up Production Target of March 2027
|
29 Jan 2026 9:57AM |
$0.005 |
$0.005 |
fallen by
0%
|
|
MRQ - Price-sensitive ASX Announcement
Full Release
Key Points
- MRG Metals and Sinowin Lithium plan production start-up by March 2027.
- 2 billion tonne Heavy Mineral Sands Project in Mozambique.
- Sinowin has invested over US$1 million in preparatory activities.
- Environmental and Social Impact Assessment permit approved.
- Resettlement Action Plan completion targeted for June 2026.
- Sinowin committed to sole-funding up to 220,000 tonnes per annum production.
- First-year production target between 130,000-160,000 tonnes.
- Five-year ramp-up objective to 800,000 tonnes per annum.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Flynn Gold Limited (FG1) ORDINARY FULLY PAID |
Materials |
$14 |
December 2025 Quarterly Activities Report and Appendix 5B
|
29 Jan 2026 9:56AM |
$0.024 |
$0.023 |
fallen by
4.17%
|
|
FG1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant assay results for gold, cobalt, and tungsten.
- Raised approximately $4.998 million through rights issue.
- Cash position at December 2025 was $3.453 million.
- Exploration activities focused on Mangana, Firetower, and Golden Ridge projects.
- High-grade mineralization zones extended at multiple prospects.
- Quarterly expenditures included exploration, employee costs, and administration.
- Plans for further exploration and mineral resource estimates in first half of CY2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Titan Minerals Limited (TTM) ORDINARY FULLY PAID |
Materials |
$287 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Jan 2026 9:56AM |
$1.050 |
$1.000 |
fallen by
4.76%
|
|
TTM - Price-sensitive ASX Announcement
Full Release
Key Points
- Titan Minerals Limited reported for the quarter ending 31 December 2025.
- Advanced the Dynasty Gold Project in Ecuador, focusing on the Cerro Verde prospect.
- Conducted infill and extensional drilling, with a Mineral Resource update expected in Q1 2026.
- New drilling revealed potential for rapid resource growth and additional mineralization.
- Financials showed $12,032,000 in cash at end of period, with $740,000 net cash used in operations.
- Invested $2,191,000 in exploration activities during the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Alpha HPA Limited (A4N) ORDINARY FULLY PAID |
Materials |
$833 |
Capital Raising Presentation
|
29 Jan 2026 9:56AM |
$0.845 |
$0.730 |
fallen by
13.61%
|
|
| Farm Pride Foods Limited (FRM) ORDINARY FULLY PAID |
Consumer Staple |
$55 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jan 2026 9:55AM |
$0.210 |
$0.240 |
risen by
14.29%
|
|
FRM - Price-sensitive ASX Announcement
Full Release
Key Points
- Farm Pride Foods Limited reported a net operating cash inflow of $4.566 million.
- Receipts from customers were $32.560 million, up 3% from the previous quarter.
- Invested $2.585 million in infrastructure for farming and production.
- Achieved highest audit standards from Coles for the Keysborough facility.
- Rising egg volumes and pricing pressures presented challenges.
- Focus on capital expenditure and operational improvements to boost efficiency.
- No net cash from financing activities during the quarter.
- Secured a $27.568 million facility with NAB, with $12 million drawdown.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ioneer Ltd (INR) ORDINARY FULLY PAID |
Materials |
$415 |
Trading Halt
|
29 Jan 2026 9:55AM |
$0.210 |
$0.155 |
fallen by
26.19%
|
|
INR - Price-sensitive ASX Announcement
Full Release
Key Points
- Trading halt requested by ioneer Ltd (ASX: INR)
- Halt pending announcement on material capital raising
- Halt remains until 2 February 2026 or earlier announcement
- Request made under ASX Listing Rule 17.1
- No known reasons against granting the halt
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
